Eliem Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Eliem Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q2 2024.
  • Eliem Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 4.49K %, a 87% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 4.49K +2.09K +87% Jun 30, 2024
Q1 2024 3.63K +1.54K +73.4% Mar 31, 2024
Q4 2023 3.2K +1.22K +61.3% Dec 31, 2023
Q3 2023 2.75K +703 +34.4% Sep 30, 2023
Q2 2023 2.4K +207 +9.43% Jun 30, 2023
Q1 2023 2.09K -158 -7.03% Mar 31, 2023
Q4 2022 1.99K Dec 31, 2022
Q3 2022 2.04K Sep 30, 2022
Q2 2022 2.19K Jun 30, 2022
Q1 2022 2.25K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.